From GlobeNewswire: 2024-06-20 09:00:00

The Global Morphine Market is projected to grow from USD 22.46 billion in 2023 to USD 34.87 billion by 2033, with a CAGR of 4.50%. Morphine, derived from the opium poppy plant, is a potent prescription opioid used for pain relief and anesthesia. The market is expanding due to increasing demand for potent analgesics like morphine for chronic pain management.

The oral tablets segment is expected to dominate the global morphine market, offering a convenient and long-lasting pain relief solution for patients. In terms of application, anesthesia is projected to grow rapidly due to its essential role in surgical procedures. The hospitals & clinics segment is predicted to have the highest growth in the market.

North America is forecasted to hold the largest share of the global morphine market, with the United States leading the region due to its advanced healthcare system. Meanwhile, Asia Pacific is expected to grow at a rapid pace, driven by increasing healthcare costs and the expansion of healthcare facilities in countries like China and India.

Major vendors in the global morphine market include Fresenius Kabi USA, Purdue Pharma, Sun Pharmaceutical Industries Ltd, and more. Recent developments include the launch of a new morphine sulfate injection in China. Market segment analysis includes type, application, end user, and regional insights for better understanding and strategic decision-making.



Read more at GlobeNewswire: Global Morphine Market Size To Worth USD 34.87 Billion By